A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas
- PMID: 22828612
- PMCID: PMC3464765
- DOI: 10.1038/bjc.2012.302
A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas
Abstract
Background: Papillary thyroid cancer (PTC) incidence increased dramatically in children after the Chernobyl accident, providing a unique opportunity to investigate the molecular features of radiation-induced thyroid cancer. In contrast to the previous studies that included age-related confounding factors, we investigated mRNA expression in PTC and in the normal contralateral tissues of patients exposed and non-exposed to the Chernobyl fallout, using age- and ethnicity-matched non-irradiated cohorts.
Methods: Forty-five patients were analysed by full-genome mRNA microarrays. Twenty-two patients have been exposed to the Chernobyl fallout; 23 others were age-matched and resident in the same regions of Ukraine, but were born after 1 March 1987, that is, were not exposed to ¹³¹I.
Results: A gene expression signature of 793 probes corresponding to 403 genes that permitted differentiation between normal tissues from patients exposed and from those who were not exposed to radiation was identified. The differences were confirmed by quantitative RT-PCR. Many deregulated pathways in the exposed normal tissues are related to cell proliferation.
Conclusion: Our results suggest that a higher proliferation rate in normal thyroid could be related to radiation-induced cancer either as a predisposition or as a consequence of radiation. The signature allows the identification of radiation-induced thyroid cancers.
© 2012 Cancer Research UK
Figures


Similar articles
-
Comparison of transcriptomic signature of post-Chernobyl and postradiotherapy thyroid tumors.Thyroid. 2013 Nov;23(11):1390-400. doi: 10.1089/thy.2012.0318. Epub 2013 Sep 19. Thyroid. 2013. PMID: 23521174
-
Gene signature of the post-Chernobyl papillary thyroid cancer.Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1267-77. doi: 10.1007/s00259-015-3303-3. Epub 2016 Jan 26. Eur J Nucl Med Mol Imaging. 2016. PMID: 26810418 Free PMC article.
-
Gene expression profiles for radiation-induced thyroid cancer.Clin Oncol (R Coll Radiol). 2011 May;23(4):282-8. doi: 10.1016/j.clon.2011.01.509. Epub 2011 Mar 15. Clin Oncol (R Coll Radiol). 2011. PMID: 21411301 Review.
-
Papillary Thyroid Carcinoma in Ukraine After Chernobyl and in Japan After Fukushima: Different Histopathological Scenarios.Thyroid. 2021 Sep;31(9):1322-1334. doi: 10.1089/thy.2020.0308. Epub 2020 Dec 3. Thyroid. 2021. PMID: 33143557
-
Radiation-induced thyroid cancer: what we have learned from chernobyl.Endocr Pathol. 2006 Winter;17(4):307-17. doi: 10.1007/s12022-006-0001-5. Endocr Pathol. 2006. PMID: 17525478 Review.
Cited by
-
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.Onco Targets Ther. 2021 Feb 22;14:1205-1217. doi: 10.2147/OTT.S294725. eCollection 2021. Onco Targets Ther. 2021. PMID: 33654411 Free PMC article.
-
Major Vault Protein (MVP) Associated With BRAF V600E Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer via MAPK/ERK and PI3K/AKT Pathways.Front Cell Dev Biol. 2022 Mar 31;9:688370. doi: 10.3389/fcell.2021.688370. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35433709 Free PMC article.
-
Association of High Serum Leptin Level with Papillary Thyroid Carcinoma: A Case-Control Study.Int J Hematol Oncol Stem Cell Res. 2023 Jul 1;17(3):210-219. doi: 10.18502/ijhoscr.v17i3.13311. Int J Hematol Oncol Stem Cell Res. 2023. PMID: 37817973 Free PMC article.
-
The diagnostic or prognostic values of FADD in cancers based on pan‑cancer analysis.Biomed Rep. 2023 Sep 11;19(5):77. doi: 10.3892/br.2023.1659. eCollection 2023 Nov. Biomed Rep. 2023. PMID: 37829257 Free PMC article.
-
Tumor Microbial Communities and Thyroid Cancer Development-The Protective Role of Antioxidant Nutrients: Application Strategies and Future Directions.Antioxidants (Basel). 2023 Oct 23;12(10):1898. doi: 10.3390/antiox12101898. Antioxidants (Basel). 2023. PMID: 37891977 Free PMC article. Review.
References
-
- Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D (1992) Thyroid-cancer after Chernobyl. Nature 359(6390): 21–22 - PubMed
-
- Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio MD, Carosella ED (2005) Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging 32(2): 229–246 - PubMed
-
- Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97(10): 724–732 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases